Get the full picture
Sign in to uncover key details.
Applied Stemcell
Business Services · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
521 Cottonwood Dr Ste 111, Milpitas, Cal...Phone Number
(408) 773-8007Website
www.appliedstemcell.comRevenue
$66.4 MillionIndustry
About Applied Stemcell
Applied StemCell specializes in advanced genome engineering technologies and induced pluripotent stem cell (iPSC) expertise, aimed at facilitating the development of next-generation therapeutics. Their offerings include a range of genome engineering platforms such as TARGATT technology, CRISPR/Cas9, and various iPSC services including drug discovery and gene editing. The company provides cGMP services for cell banking and manufacturing, ensuring high-quality standards for therapeutic applications. Founded in 2008, Applied StemCell is committed to supporting the discovery and development of cell therapies for a diverse clientele in the biopharmaceutical industry.Explore more
Applied Stemcell Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Applied Stemcell
Compare insights from companies similar to Applied Stemcell, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Applied Stemcell Tech Stack
A closer look at the technologies used by Applied Stemcell
See more technologies
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Applied Stemcell
Sign Up For FreeTo access detailed company insights
Applied StemCell specializes in advanced genome engineering technologies and induced pluripotent stem cell (iPSC) expertise, aimed at facilitating the development of next-generation therapeutics. Their offerings include a range of genome engineering platforms such as TARGATT technology, CRISPR/Cas9, and various iPSC services including drug discover... Read More
